Status:
UNKNOWN
Determination of Glycemic and Insulinemic Indices
Lead Sponsor:
Finnish Institute for Health and Welfare
Conditions:
Glucose Metabolism
Eligibility:
All Genders
20-72 years
Phase:
NA
Brief Summary
The aim of this study to investigate methodological aspects that may affect glycemic index (GI) and insulinemic (II) values. In addition, we will measure GI and II values for typical Finnish carbohydr...
Eligibility Criteria
Inclusion
- For Studies 1-9 a total of 12 to 24 volunteers per study with a normal glucose tolerance based upon a 2 h 75g oral glucose tolerance test (OGTT).
- For Study 7 a total of 24 volunteers with impaired glucose tolerance based on an OGTT.
- For Studies 1-6 and 8-9 with an age of 20 to 60 and with a BMI of 18 to 30 kg/m2.
- For Study 7 an age of 62 to 72 and with a BMI of 20 to 35 kg/m2.
Exclusion
- First-degree family history of diabetes
- An active gastrointestinal or metabolic disease
- For Studies 1-6 and 8-9 chronic medication (oral contraceptives were allowed)
- For Study 7 regular medication that would have affect glucose and lipid metabolism
- Smoking
- Pregnancy
- Breastfeeding
- History of polycystic ovary syndrome
- History of gestational diabetes
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT01477216
Start Date
January 1 2003
End Date
December 1 2013
Last Update
November 22 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.